Alan Bradley
Oprichter bij Kymab Group Ltd.
Actieve functies van Alan Bradley
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Sieger Healthcare Acquisition Corp.
Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | Directeur/Bestuurslid | - | - |
Independent Dir/Board Member | - | - | |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Hoofd Techniek/Wetenschap/O&O | - | - |
Oprichter | - | - | |
University of Cambridge | Corporate Officer/Principal | - | - |
Loopbaan van Alan Bradley
Eerdere bekende functies van Alan Bradley
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ExpressionEdits Ltd. | Oprichter | - | - |
Baylor College of Medicine | Corporate Officer/Principal | - | - |
LEXICON PHARMACEUTICALS, INC. | Oprichter | - | - |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | - | - |
Spectral Genomics, Inc.
Spectral Genomics, Inc. BiotechnologyHealth Technology Spectral Genomics is a biotechnology company that makes DNA microarrays and chips which can be used in cloning and genome profiling. Its arrays are made from bacterial artificial chromosomes (BACs). The company's Spectral Chip and Constitutional Chip are designed to highlight the genome's spots in research. The company supplies BAC clones to university laboratories and biotech and pharmaceutical research and development facilities. Spectral Genomics also sells the SpectralWare Array Analysis System, software designed for use in conjunction with the company's arrays. Spectral Genomics is headquartered in Houston, TX | Oprichter | 01-02-2000 | - |
Opleiding van Alan Bradley
University of Cambridge | Doctorate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 5 |
Verenigde Staten | 4 |
Singapore | 2 |
Operationeel
Founder | 5 |
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Spectral Genomics, Inc.
Spectral Genomics, Inc. BiotechnologyHealth Technology Spectral Genomics is a biotechnology company that makes DNA microarrays and chips which can be used in cloning and genome profiling. Its arrays are made from bacterial artificial chromosomes (BACs). The company's Spectral Chip and Constitutional Chip are designed to highlight the genome's spots in research. The company supplies BAC clones to university laboratories and biotech and pharmaceutical research and development facilities. Spectral Genomics also sells the SpectralWare Array Analysis System, software designed for use in conjunction with the company's arrays. Spectral Genomics is headquartered in Houston, TX | Health Technology |
Sieger Healthcare Acquisition Corp.
Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | Finance |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Health Technology |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
ExpressionEdits Ltd. | Commercial Services |
- Beurs
- Insiders
- Alan Bradley
- Ervaring